bismuth subsalicylate 262 MG Oral Tablet
RxNorm concept 308760, clinical drug (scd).
- RxCUI
- 308760
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/308760 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- bismuth subsalicylate 262 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- bismuth subsalicylate 262 MG Oral Tablet [Kaopectate Reformulated Aug 2006] (SBD, has tradename)
- bismuth subsalicylate 262 MG Oral Tablet [Pepto-bismol] (SBD, has tradename)
Linked data
NDCs
- 00363034610
- 00363912540
- 11673012248
- 11673012520
- 11673088044
- 11822125400
- 21130012540
- 24385001758
- 30142052424
- 36800010428
- 37808034608
- 41163012328
- 41226047542
- 41250032440
- 42507070728
- 49035034610
- 49348051159
- 50428608802
- 58933001712
- 58933001724
- 63868017140
- 63868069140
- 66715684104
- 69842017212
- 69842017228
- 69842034612
- 69842034628
- 70000059401
- 70677108201
- 72288012540
- 76077108201
- 83324006040
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 308760 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/308760 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 308760. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.